Cynthia J. Ladd, Senior VP and General Counsel at CytomX Therapeutics, Inc. (CTMX), bought 3,000 shares at $12.00 ($36K) on 2015-10-14, disclosed to the SEC on 2015-10-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.